HIF1 plays a dual role in T cell differentiation by binding to FoxP3, promoting its proteasomal degradation and thereby inhibiting Treg cell development [140]
Miyashita A, Ito J, Parida IS, Syoji N, Fujii T, Takahashi H, et al
Zhang, W., Trachootham, D., Liu, J., Chen, G., Pelicano, H., Garcia-Prieto, C
Then, these cells were stimulated to the osteoclast phenotype with 30 ng/mL M-CSF and 50 ng/mL RANKL and treated by SP (2.5 10 6 cells/mL) or MTX (4 M) for 0, 1, 3, 5 days
E., & Shatzel, J
For injury healing (muscles, tendons, ligaments) Standard protocol: Dose: 250-500mcg twice daily (500mcg-1mg total daily) Method: Injectable SubQ near injury site Duration: 4-8 weeks minimum Timing: Morning and evening Severe injuries: Dose: 500mcg twice daily (1mg total daily) Method: Injectable SubQ Duration: 8-12 weeks Can extend if needed Mild injuries: Dose: 250mcg twice daily (500mcg total) Method: Injectable SubQ Duration: 4-6 weeks Use our BPC-157 dosage calculator and BPC-157 5mg dosing guide